Clinical outcomes subject to formal monitoring in the WHI Hormone
Download Table | Clinical outcomes subject to formal monitoring in the WHI Hormone Therapy Trial component from publication: Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials | The Women's Health Initiative (WHI) randomized trial of estrogen plus progestin (E + P) was terminated early based on an assessment of harms exceeding benefits for disease prevention. The results contravened prevailing wisdom and a large body of literature regarding benefits | Women's Health, Estrogen Replacement Therapy and Estrogens | ResearchGate, the professional network for scientists.
NCSBN's Environmental Scan A Portrait of Nursing and Healthcare in
The Clinical Impact of the Women's Health Initiative (WHI
PDF) Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials
The Clinical Impact of the Women's Health Initiative (WHI
Oestrogen and anti-androgen therapy for transgender women - The
Effects of Hormone Therapy on survival, cancer, cardiovascular and
Ross L Prentice's research works University of Washington Seattle, Seattle (UW) and other places
The Clinical Impact of the Women's Health Initiative (WHI
Androgen Physiology, Pharmacology, Use and Misuse - Endotext
Plasma proteins related to inflammatory diet predict future
